United States · Who invested in EKR Therapeutics?
EKR Therapeutics's investors include Quaker Partners, NewSpring, Merrill Lynch, ESP Equity Partners and Garden State Life Sciences Venture.
United States · Series C startup
Who invested in EKR Therapeutics
Funding summaryUpdated 26 Oct 2026
$13Mraised across 1 round since 2007, from 1 source
- Latest round
- Series C, $13MAug 2007
- Investors
- 5
The rounds
- Aug 2007Series C$13M
Quaker Partners
NewSpring
Merrill Lynch- ESP Equity Partners
- Garden State Life Sciences Venture
From a historical funding record
The exit
ExitBuyerPriceWhen
AcquiredCornerstone Therapeutics$150MMay 2012
From historical deal records. Wrong? Tell us.
Everyone who backed them
ESP Equity Partnersno record of our own yet1round
Garden State Life Sciences Ventureno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about EKR Therapeutics
How much has EKR Therapeutics raised?
EKR Therapeutics has raised $13M across 1 round since 2007.
When did EKR Therapeutics last raise?
EKR Therapeutics's most recent round was a Series C of $13M in Aug 2007.
What was EKR Therapeutics's biggest round?
Its most recent round, $13M in Aug 2007, is also its largest on record.
Who backed EKR Therapeutics first?
EKR Therapeutics's first round on record, in Aug 2007, was backed by Quaker Partners, NewSpring and Merrill Lynch and 2 others.
What stage is EKR Therapeutics at?
EKR Therapeutics's latest named round is a Series C, in Aug 2007.
Where is EKR Therapeutics based?
EKR Therapeutics is based in the United States.
Companies like EKR Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.